Theravence Prices 7.5 Million Share Offering at 4.1% Discount to Thursday's Close (THRX)
Friday, March 19, 2010 - 09:38
Written on Fri, 03/19/2010 - 9:38am
By Chip Brian

3/19/2010-Dow Jones reported Thursday that Theravance (NASDAQ:THRX) said its planned sale of at least 7.5 million shares was priced at a 4.1% discount to Thursday's close.
Shares of the development-stage biotechnology company--which targets pain management, respiratory, urogenital and infectious diseases--are trading at $11.95, compared with the
$11.50 offer price.
There are about 64 million shares outstanding.
Potential uses for the fresh capital include funding drug studies.

Keywords: theravence Offering pricing discount

Ticker(s): THRX

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.